Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir

Tenofovir disoproxil fumarate (TDF) is widely used to treat hepatitis B virus (HBV) patients in the USA and Europe. No confirmed report of resistance selection during treatment with TDF in treatment-naïve and nucleoside/nucleotide analog-treated chronic hepatitis B patients has yet been reported. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Fumitaka, Sezaki, Hitomi, Akuta, Norio, Suzuki, Yoshiyuki, Kawamura, Yusuke, Hosaka, Tetsuya, Kobayashi, Masahiro, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kobayashi, Mariko, Watahiki, Sachiyo, Mineta, Rie, Suzuki, Yukiko, Kumada, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085295/
https://www.ncbi.nlm.nih.gov/pubmed/25061278
http://dx.doi.org/10.2147/DDDT.S65349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085295/
https://www.ncbi.nlm.nih.gov/pubmed/25061278
http://dx.doi.org/10.2147/DDDT.S65349

Ejemplares similares